Neuroprotective effect of recombinant human erythropoietin on optic nerve injury in rats

Chinese Medical Journal

Volumn 122, Issue 17, 2009, Pages 2008-2012

  Wang, Hui ^a   Liu, Zhe Li ^a   Zhuang, Xiao Tong ^b   Wang, Min Fang ^b   Xu, Li ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Department of Radiology   (China)

Author keywords

Erythropoietin; Growth associated protein 43; Optic nerve injuries; Retinal ganglion cells

Indexed keywords

NEUROMODULIN; RECOMBINANT ERYTHROPOIETIN; SODIUM CHLORIDE;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL REGENERATION; CONTROLLED STUDY; CRUSH TRAUMA; EVOKED VISUAL RESPONSE; IMMUNOHISTOCHEMISTRY; LATENT PERIOD; NERVE CONDUCTION; NERVE FIBER REGENERATION; NEUROPROTECTION; NONHUMAN; OPTIC NERVE INJURY; PROTEIN EXPRESSION; RANDOMIZATION; RAT; RETINA; TISSUE REPAIR;

ANIMALS; ERYTHROPOIETIN, RECOMBINANT; EVOKED POTENTIALS, VISUAL; GAP-43 PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; NEUROPROTECTIVE AGENTS; OPTIC NERVE; OPTIC NERVE INJURIES; RANDOM ALLOCATION; RATS; RATS, WISTAR; RETINA;

EID: 70350525692     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.17.009     Document Type: Article

References (24)

1. Margalit E, Sadda SR. Retinal and optic nerve diseases. Artif Organs 2003; 27: 963-974.
2. Brines M, Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci 2005; 6: 484-494. (Pubitemid 40769173)
3. Levkovitch-Verbin H, Quigley HA, Martin KR, Zack DJ, Pease ME, Valenta DF. A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transection. Invest Ophthalmol Vis Sci 2003; 44: 3388-3393. (Pubitemid 36909775)
4. Levin LA. Retinal ganglion cells and neuroprotection for glaucoma. Surv Ophthalmol 2003; 48: S21-S24. (Pubitemid 41126692)
5. So KF, Aquayo AJ. Lengthy regrowth of cut axons from ganglion cells after peripheral nerve transplantation into the retina of adult rats. Brain Res 1985; 328: 349-354.
6. Campbell G, Holt JK, Shotton HR, Anderson PN, Bavetta S, Lieberman AR. Spontaneous axonal regeneration after optic nerve injury in adult rat. Neuroreport 1999; 10: 3955-3960. (Pubitemid 30004863)
7. Zhou MH. Neurotrophic factors. In: Han JS, ed. Principles in neuroscience. Beijing: Beijing Medical Univerisity Press; 1999: 1033-1034.
8. Poduslo JF, Curran GL. Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Brain Res Mol Brain Res 1996; 36: 280-286.
9. Young LS, Mautner V. The promise and potential hazards of adenovirus gene therapy. Gut 2001; 48: 733-736. (Pubitemid 32378601)
10. Warren SM, Fong KD, Chen CM, Loboa EG, Cowan CM, Lorenz HP, et al. Tools and techniques for craniofacial tissue engineering. Tissue Eng 2003; 9: 187-200.
11. Miura O, Nakamura N, Quelle FW, Witthuhn BA, Ihle JN, Aoki N. Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vivo. Blood 1994; 84: 1501-1507. (Pubitemid 24273018)
12. Jelkmann W. Erythropoietin: structure, control of production, and function. Physinl Rev 1992; 72: 449-489.
13. Wiessner C, Allegrini PR, Ekatodramis D, Jewell UR, Stallmach T, Gassmann M. Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin. J Cereb Blood Flow Metab 2001; 21: 857-864. (Pubitemid 32613540)
14. Heinicke K, Baum O, Ogunshola OO, Vogel J, Stallmach T, Wolfer DP, et al. Excessive erythrocytosis in adult mice overexpressing erythropoietin leads to hepatic, renal, neuronal, and muscular degeneration. Am J Physiol Regul Integr Comp Physiol 2006; 291: R947-R956. (Pubitemid 44498434)
15. Kilic U, Kilic E, Soliz J, Bassetti CL, Gassmann M, Hermann DM. Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2. Faseb J 2005; 19: 249-251. (Pubitemid 40189271)
16. Weishaupt JH, Rohde G, Polking E, Siren AL, Ehrenreich H, Bahr M. Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells. Invest Ophthalmol Vis Sic 2004; 45: 1514-1535. (Pubitemid 38859333)
17. Miyake K, Yoshida M, Inoue Y, Hata Y. Neuroprotective effect of transcorneal electrical stimulation on the acute phase of optic nerve injury. Invest Ophthalmol Vis Sci 2007; 48: 2356-2361. (Pubitemid 351261317)
18. Perrone-Bizzozero NI, Sower AC, Bird ED, Benowitz LI, Ivins KJ, Neve RL. Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia. Proc Natl Acad Sci U S A 1996; 93: 14182-14187.
19. Dusart I, Ghoumari A, Wehrle R, Morel MP, Bouslama-Oueghlani L, Camand E, et al. Cell death and axon regeneration of Purkinje cells after axotomy: challenges of classical hypotheses of axon regeneration. Brain Res Brain Res Rev 2005; 49: 300-316. (Pubitemid 41160398)
20. Plunet W, Kwon BK, Tetzlaff W. Promoting axonal regeneration in the central nervous system by enhancing the cell body response to axotomy. J Neurosci Res 2002; 68: 1-6. (Pubitemid 34274991)
21. Parisi V, Coppola G, Ziccardi L, Gallinaro G, Falsini B. Cytidine-5′-diphosphocholine (Citicoline): a pilot study in patients with non-arteritic ischaemic optic neuropathy. Eur J Neurol 2008; 15: 465-474.
22. Sabel BA, Aschoff A. Functional recovery and morphological changes after injury to the optic nerve. Neuropsychobiology 1993; 22: 62-65. (Pubitemid 23283752)
23. Heiduschka P, Fischer D, Thanos S. Recovery of visual evoked potentials after regeneration of cut retinal ganglion cell axons within the ascending visual pathway in adult rats. Restor Neurol Neurosci 2005; 23: 303-312. (Pubitemid 41746164)
24. Kremlácek J, Hosák L, Kuba M, Libiger J, Cízek J. Visual information processing in recently abstaining methamphetamine-dependent individuals: evoked potentials study. Doc Ophthalmol 2008; 117: 245-255.